AFP and cirrhosis of liver: In the multivariate analyses, serum AFP > 15 ng/mL (HR, 1.799; 95% CI, 1.089–2.970; p = 0.022), liver cirrhosis (HR, 2.062; 95% CI, 1.247–3.410; p = 0.005), microvascular invasion (HR, 2.331; 95% CI, 1.408–3.860; p = 0.001) and no-DAA treatment (HR, 4.978; 95% CI, 1.976–12.542; p = 0.001) remained independent prognostic factors for RFS.